Vagus nerve stimulation for medically refractory absence epilepsy
A proportion of patients with childhood and juvenile absence epilepsies (CAE, JAE) are likely to be classified as medically refractory. In view of evidence gap for the treatment of such patients, this series is reported to generate estimate for efficacy of vagus nerve stimulation (VNS) in this patie...
Uloženo v:
| Vydáno v: | Seizure (London, England) Ročník 22; číslo 4; s. 267 - 270 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
Elsevier Ltd
01.05.2013
|
| Témata: | |
| ISSN: | 1059-1311, 1532-2688, 1532-2688 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | A proportion of patients with childhood and juvenile absence epilepsies (CAE, JAE) are likely to be classified as medically refractory. In view of evidence gap for the treatment of such patients, this series is reported to generate estimate for efficacy of vagus nerve stimulation (VNS) in this patient population.
Patients were identified by a chart review of all VNS recipients between January 1, 2006 and December 31, 2011. The diagnosis of CAE and JAE was based on conventional criteria. Details of demography, epilepsy phenomenology, management and outcomes were extracted. The outcome measures included reduction in daily seizure frequency measured as a percentage of pre-VNS seizure frequency and classified on International League Against Epilepsy (ILAE) outcome scale.
Nine patients (7 CAE, 2 JAE) with a mean age of seizure onset of 5.4 years (±3.9) were identified. Mean duration of epilepsy prior to VNS implant was found to be 3.9 years (±1.4). These patients had failed a median of 5 anti-epileptic drugs before being referred for consideration of surgical treatment. After a mean follow-up of 33.9 months (±25.5, minimum 4 months), 1 patient attained complete seizure freedom (ILAE class 1), 6 had ILAE class 4 and 2 had ILAE class 5 outcomes, respectively. Mean reduction in daily seizure frequency was found to be 53.5±60.3% (1-sided p-value for paired t-test=0.04), with a 50% responder rate of 55.6%.
VNS may be considered as a therapeutic option in patients with medically refractory absence epilepsy. |
|---|---|
| AbstractList | A proportion of patients with childhood and juvenile absence epilepsies (CAE, JAE) are likely to be classified as medically refractory. In view of evidence gap for the treatment of such patients, this series is reported to generate estimate for efficacy of vagus nerve stimulation (VNS) in this patient population.
Patients were identified by a chart review of all VNS recipients between January 1, 2006 and December 31, 2011. The diagnosis of CAE and JAE was based on conventional criteria. Details of demography, epilepsy phenomenology, management and outcomes were extracted. The outcome measures included reduction in daily seizure frequency measured as a percentage of pre-VNS seizure frequency and classified on International League Against Epilepsy (ILAE) outcome scale.
Nine patients (7 CAE, 2 JAE) with a mean age of seizure onset of 5.4 years (±3.9) were identified. Mean duration of epilepsy prior to VNS implant was found to be 3.9 years (±1.4). These patients had failed a median of 5 anti-epileptic drugs before being referred for consideration of surgical treatment. After a mean follow-up of 33.9 months (±25.5, minimum 4 months), 1 patient attained complete seizure freedom (ILAE class 1), 6 had ILAE class 4 and 2 had ILAE class 5 outcomes, respectively. Mean reduction in daily seizure frequency was found to be 53.5±60.3% (1-sided p-value for paired t-test=0.04), with a 50% responder rate of 55.6%.
VNS may be considered as a therapeutic option in patients with medically refractory absence epilepsy. Abstract Purpose A proportion of patients with childhood and juvenile absence epilepsies (CAE, JAE) are likely to be classified as medically refractory. In view of evidence gap for the treatment of such patients, this series is reported to generate estimate for efficacy of vagus nerve stimulation (VNS) in this patient population. Methods Patients were identified by a chart review of all VNS recipients between January 1, 2006 and December 31, 2011. The diagnosis of CAE and JAE was based on conventional criteria. Details of demography, epilepsy phenomenology, management and outcomes were extracted. The outcome measures included reduction in daily seizure frequency measured as a percentage of pre-VNS seizure frequency and classified on International League Against Epilepsy (ILAE) outcome scale. Results Nine patients (7 CAE, 2 JAE) with a mean age of seizure onset of 5.4 years (±3.9) were identified. Mean duration of epilepsy prior to VNS implant was found to be 3.9 years (±1.4). These patients had failed a median of 5 anti-epileptic drugs before being referred for consideration of surgical treatment. After a mean follow-up of 33.9 months (±25.5, minimum 4 months), 1 patient attained complete seizure freedom (ILAE class 1), 6 had ILAE class 4 and 2 had ILAE class 5 outcomes, respectively. Mean reduction in daily seizure frequency was found to be 53.5 ± 60.3% (1-sided p -value for paired t -test = 0.04), with a 50% responder rate of 55.6%. Conclusion VNS may be considered as a therapeutic option in patients with medically refractory absence epilepsy. A proportion of patients with childhood and juvenile absence epilepsies (CAE, JAE) are likely to be classified as medically refractory. In view of evidence gap for the treatment of such patients, this series is reported to generate estimate for efficacy of vagus nerve stimulation (VNS) in this patient population.PURPOSEA proportion of patients with childhood and juvenile absence epilepsies (CAE, JAE) are likely to be classified as medically refractory. In view of evidence gap for the treatment of such patients, this series is reported to generate estimate for efficacy of vagus nerve stimulation (VNS) in this patient population.Patients were identified by a chart review of all VNS recipients between January 1, 2006 and December 31, 2011. The diagnosis of CAE and JAE was based on conventional criteria. Details of demography, epilepsy phenomenology, management and outcomes were extracted. The outcome measures included reduction in daily seizure frequency measured as a percentage of pre-VNS seizure frequency and classified on International League Against Epilepsy (ILAE) outcome scale.METHODSPatients were identified by a chart review of all VNS recipients between January 1, 2006 and December 31, 2011. The diagnosis of CAE and JAE was based on conventional criteria. Details of demography, epilepsy phenomenology, management and outcomes were extracted. The outcome measures included reduction in daily seizure frequency measured as a percentage of pre-VNS seizure frequency and classified on International League Against Epilepsy (ILAE) outcome scale.Nine patients (7 CAE, 2 JAE) with a mean age of seizure onset of 5.4 years (±3.9) were identified. Mean duration of epilepsy prior to VNS implant was found to be 3.9 years (±1.4). These patients had failed a median of 5 anti-epileptic drugs before being referred for consideration of surgical treatment. After a mean follow-up of 33.9 months (±25.5, minimum 4 months), 1 patient attained complete seizure freedom (ILAE class 1), 6 had ILAE class 4 and 2 had ILAE class 5 outcomes, respectively. Mean reduction in daily seizure frequency was found to be 53.5±60.3% (1-sided p-value for paired t-test=0.04), with a 50% responder rate of 55.6%.RESULTSNine patients (7 CAE, 2 JAE) with a mean age of seizure onset of 5.4 years (±3.9) were identified. Mean duration of epilepsy prior to VNS implant was found to be 3.9 years (±1.4). These patients had failed a median of 5 anti-epileptic drugs before being referred for consideration of surgical treatment. After a mean follow-up of 33.9 months (±25.5, minimum 4 months), 1 patient attained complete seizure freedom (ILAE class 1), 6 had ILAE class 4 and 2 had ILAE class 5 outcomes, respectively. Mean reduction in daily seizure frequency was found to be 53.5±60.3% (1-sided p-value for paired t-test=0.04), with a 50% responder rate of 55.6%.VNS may be considered as a therapeutic option in patients with medically refractory absence epilepsy.CONCLUSIONVNS may be considered as a therapeutic option in patients with medically refractory absence epilepsy. |
| Author | Gonsalves, Cornelia Mangano, Francesco T. Greiner, Hansel M. Glauser, Tracy A. Arya, Ravindra Lewis, Amanda Holland, Katherine D. |
| Author_xml | – sequence: 1 givenname: Ravindra surname: Arya fullname: Arya, Ravindra email: ravindra.arya4@gmail.com, Ravindra.Arya@cchmc.org organization: Comprehensive Epilepsy Center, Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States – sequence: 2 givenname: Hansel M. surname: Greiner fullname: Greiner, Hansel M. organization: Comprehensive Epilepsy Center, Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States – sequence: 3 givenname: Amanda surname: Lewis fullname: Lewis, Amanda organization: Comprehensive Epilepsy Center, Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States – sequence: 4 givenname: Francesco T. surname: Mangano fullname: Mangano, Francesco T. organization: Division of Pediatric Neurosurgery, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States – sequence: 5 givenname: Cornelia surname: Gonsalves fullname: Gonsalves, Cornelia organization: Comprehensive Epilepsy Center, Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States – sequence: 6 givenname: Katherine D. surname: Holland fullname: Holland, Katherine D. organization: Comprehensive Epilepsy Center, Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States – sequence: 7 givenname: Tracy A. surname: Glauser fullname: Glauser, Tracy A. organization: Comprehensive Epilepsy Center, Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23391567$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkktv1TAQhS1URB_wE0BZskkY24mTCEFVVUCRKrHgsbWcyQT54htf7KRS-uvrcC8sKlVlZcs658jznTllR6MfibGXHAoOXL3ZFJHs7RyoEMBlAbwAaJ6wE15JkQvVNEfpDlWbc8n5MTuNcQMAbcnlM3YspGx5peoTdvHD_JxjNlK4oSxOdjs7M1k_ZoMP2ZZ6i8a5JQs0BIOTD0tmukgjUkY762gXl-fs6WBcpBeH84x9__jh2-VVfv3l0-fLi-scq6ae8qHGErBD0SEIgEoZgdBi1_alBNOpFrksy7JWdd-B7Ac1mL41Td9ieqFSyTP2ep-7C_73THHSWxuRnDMj-TlqLoXipZAASfrqIJ27NIPeBbs1YdF_x06Cai_A4GNMw_2TcNArXr3RB7x6xauB64Q3-d7e86Gd_vCagrHuUff53k0J042loCPalWVvA-Gke28fTXh_LwGdHdeOftFCcePnMKYONNdRaNBf1wVY--eJSiq_SgHvHg74jw_cAfv6w9w |
| CitedBy_id | crossref_primary_10_1016_j_seizure_2024_01_019 crossref_primary_10_1016_j_yebeh_2013_05_021 crossref_primary_10_1016_j_arcped_2016_08_005 crossref_primary_10_3390_ijms25010091 crossref_primary_10_1227_NEU_0000000000001165 crossref_primary_10_4103_0028_3886_302476 crossref_primary_10_1016_j_ejpn_2015_07_008 crossref_primary_10_1016_j_pediatrneurol_2016_02_016 crossref_primary_10_1007_s00405_021_06943_x crossref_primary_10_1016_j_neurol_2024_01_002 crossref_primary_10_1016_j_neurol_2023_11_010 crossref_primary_10_1016_j_yebeh_2018_06_032 crossref_primary_10_1016_j_eplepsyres_2014_06_020 crossref_primary_10_1007_s12098_020_03423_8 crossref_primary_10_1016_j_eplepsyres_2013_06_004 crossref_primary_10_1177_0883073818766599 crossref_primary_10_1177_15357597211065587 crossref_primary_10_1111_cns_13209 crossref_primary_10_1080_17512433_2021_1959317 crossref_primary_10_1016_j_pediatrneurol_2013_10_009 crossref_primary_10_3390_pediatric13040078 crossref_primary_10_1007_s00381_015_3004_z crossref_primary_10_1111_epi_12762 crossref_primary_10_1212_WNL_0000000000012030 crossref_primary_10_1016_j_seizure_2023_09_019 crossref_primary_10_1016_j_neuroscience_2017_05_038 crossref_primary_10_1016_j_pediatrneurol_2023_07_019 crossref_primary_10_1111_aor_12945 crossref_primary_10_1007_s11940_014_0290_9 |
| Cites_doi | 10.1056/NEJMoa0902014 10.1016/j.seizure.2003.09.002 10.1016/0887-8994(91)90004-5 10.1007/BF00313944 10.1212/WNL.35.4.579 10.1212/WNL.13.11.959 10.1016/j.pediatrneurol.2012.02.004 10.1016/j.seizure.2009.05.009 10.1212/WNL.0b013e3181eb58b4 10.1111/j.1528-1157.1989.tb05316.x 10.1111/j.1528-1167.2009.02397.x 10.1212/WNL.52.7.1510 10.1016/S1474-4422(02)00220-X 10.1212/WNL.47.3.802 10.1016/j.nurt.2009.01.010 10.1111/j.1600-0404.2007.00848.x 10.1001/jama.1965.03090160005001 10.1046/j.1528-1157.2001.4220282.x 10.1016/S0022-3476(05)81922-5 10.1111/j.1528-1167.2006.00377.x |
| ContentType | Journal Article |
| Copyright | 2013 British Epilepsy Association British Epilepsy Association Copyright © 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved. |
| Copyright_xml | – notice: 2013 British Epilepsy Association – notice: British Epilepsy Association – notice: Copyright © 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.seizure.2013.01.008 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1532-2688 |
| EndPage | 270 |
| ExternalDocumentID | 23391567 10_1016_j_seizure_2013_01_008 S1059131113000095 1_s2_0_S1059131113000095 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: NCATS NIH HHS grantid: UL1 TR000077 |
| GroupedDBID | --- --K --M -RU .1- .FO .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5VS 7-5 71M 8P~ 9JM 9JO AADFP AAEDT AAEDW AAGJA AAGUQ AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXLA AAXUO AAYWO ABBQC ABCQJ ABFNM ABIVO ABJNI ABMAC ABMZM ABOYX ABTEW ABWVN ABXDB ACDAQ ACGFS ACIEU ACLOT ACRLP ACRPL ACVFH ACXNI ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEBSH AEIPS AEKER AEUPX AEVXI AEXQZ AFJKZ AFPUW AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGWIK AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRLJ AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX ASPBG AVWKF AXJTR AZFZN BAWUL BKOJK BLXMC BNPGV CAG COF CS3 DIK E3Z EBS EFJIC EFKBS EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HDW HMK HMO HVGLF HZ~ IHE IXB J1W KOM LX8 M29 M41 MO0 MOBAO N9A O-L O9- OAUVE OK1 OKEIE OP~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SAE SCC SDF SDG SEL SES SEW SSB SSH SSN SSY SSZ T5K TR2 WUQ Z5R ~G- ~HD 0SF 6I. AACTN AAFTH ABVKL AFCTW AFKWA AJOXV AMFUW NCXOZ RIG AADPK AAIAV ABLVK ABYKQ AFYLN AJBFU LCYCR 9DU AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c587t-f7c40cbc2bc020056a2c09cb9d430ab69c13444767db03df6fad9a8d9c67de463 |
| ISICitedReferencesCount | 33 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000318057000003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1059-1311 1532-2688 |
| IngestDate | Sun Nov 09 10:12:29 EST 2025 Thu Apr 03 06:59:10 EDT 2025 Sat Nov 29 07:07:52 EST 2025 Tue Nov 18 22:16:46 EST 2025 Fri Feb 23 02:28:33 EST 2024 Sun Feb 23 10:18:46 EST 2025 Tue Oct 14 19:28:39 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Medically refractory epilepsy Absence seizures Juvenile absence epilepsy Vagus nerve stimulation Childhood absence epilepsy |
| Language | English |
| License | http://www.elsevier.com/open-access/userlicense/1.0 Copyright © 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c587t-f7c40cbc2bc020056a2c09cb9d430ab69c13444767db03df6fad9a8d9c67de463 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.clinicalkey.com/#!/content/1-s2.0-S1059131113000095 |
| PMID | 23391567 |
| PQID | 1326142300 |
| PQPubID | 23479 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_1326142300 pubmed_primary_23391567 crossref_primary_10_1016_j_seizure_2013_01_008 crossref_citationtrail_10_1016_j_seizure_2013_01_008 elsevier_sciencedirect_doi_10_1016_j_seizure_2013_01_008 elsevier_clinicalkeyesjournals_1_s2_0_S1059131113000095 elsevier_clinicalkey_doi_10_1016_j_seizure_2013_01_008 |
| PublicationCentury | 2000 |
| PublicationDate | 2013-05-01 |
| PublicationDateYYYYMMDD | 2013-05-01 |
| PublicationDate_xml | – month: 05 year: 2013 text: 2013-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Seizure (London, England) |
| PublicationTitleAlternate | Seizure |
| PublicationYear | 2013 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Nei, O’Connor, Liporace, Sperling (bib0050) 2006; 47 Shahar, Brand (bib0030) 1992; 121 Perry, Bailey, Kotecha, Malik, Hernandez (bib0025) 2012; 46 Ben-Menachem (bib0070) 2002; 1 Bouma, Westendorp, van Dijk, Peters, Brouwer (bib0005) 1996; 47 Shields, Lake, Chugani (bib0035) 1985; 35 Wieser, Blume, Fish, Goldensohn, Hufnagel, King (bib0060) 2001; 42 Mullen, Suls, De Jonghe, Berkovic, Scheffer (bib0090) 2010; 75 Livingston, Torres, Pauli, Rider (bib0105) 1965; 194 Akman, Montenegro, Jacob, Eck, Chiriboga, Gilliam (bib0085) 2009; 18 Hirsch, Thomas, Panayiotopoulos (bib0020) 2008 Milby, Halpern, Baltuch (bib0065) 2009; 6 Kwan, Arzimanoglou, Berg, Brodie, Allen Hauser, Mathern (bib0015) 2010; 51 Wolf, Inoue (bib0110) 1984; 231 Hedstrom, Olsson (bib0095) 1991; 7 (bib0055) 1989; 30 Glauser, Cnaan, Shinnar, Hirtz, Dlugos, Masur (bib0010) 2010; 362 Holmes, Silbergeld, Drouhard, Wilensky, Ojemann (bib0045) 2004; 13 Kostov, Larsson, Roste (bib0040) 2007; 187 Labar, Murphy, Tecoma (bib0075) 1999; 52 Spuck, Tronnier, Orosz, Schonweiler, Sepehrnia, Nowak (bib0080) 2010; 67 Currier, Kooi, Saidman (bib0100) 1963; 13 Ben-Menachem (10.1016/j.seizure.2013.01.008_bib0070) 2002; 1 Perry (10.1016/j.seizure.2013.01.008_bib0025) 2012; 46 Wieser (10.1016/j.seizure.2013.01.008_bib0060) 2001; 42 Akman (10.1016/j.seizure.2013.01.008_bib0085) 2009; 18 Shahar (10.1016/j.seizure.2013.01.008_bib0030) 1992; 121 Hirsch (10.1016/j.seizure.2013.01.008_bib0020) 2008 Currier (10.1016/j.seizure.2013.01.008_bib0100) 1963; 13 Milby (10.1016/j.seizure.2013.01.008_bib0065) 2009; 6 Kostov (10.1016/j.seizure.2013.01.008_bib0040) 2007; 187 Livingston (10.1016/j.seizure.2013.01.008_bib0105) 1965; 194 Shields (10.1016/j.seizure.2013.01.008_bib0035) 1985; 35 Mullen (10.1016/j.seizure.2013.01.008_bib0090) 2010; 75 Nei (10.1016/j.seizure.2013.01.008_bib0050) 2006; 47 Hedstrom (10.1016/j.seizure.2013.01.008_bib0095) 1991; 7 Glauser (10.1016/j.seizure.2013.01.008_bib0010) 2010; 362 Wolf (10.1016/j.seizure.2013.01.008_bib0110) 1984; 231 Kwan (10.1016/j.seizure.2013.01.008_bib0015) 2010; 51 Spuck (10.1016/j.seizure.2013.01.008_bib0080) 2010; 67 Bouma (10.1016/j.seizure.2013.01.008_bib0005) 1996; 47 (10.1016/j.seizure.2013.01.008_bib0055) 1989; 30 Holmes (10.1016/j.seizure.2013.01.008_bib0045) 2004; 13 Labar (10.1016/j.seizure.2013.01.008_bib0075) 1999; 52 |
| References_xml | – volume: 13 start-page: 340 year: 2004 end-page: 345 ident: bib0045 article-title: Effect of vagus nerve stimulation on adults with pharmacoresistant generalized epilepsy syndromes publication-title: Seizure – volume: 362 start-page: 790 year: 2010 end-page: 799 ident: bib0010 article-title: Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy publication-title: New England Journal of Medicine – volume: 187 start-page: 55 year: 2007 end-page: 58 ident: bib0040 article-title: Is vagus nerve stimulation a treatment option for patients with drug-resistant idiopathic generalized epilepsy? publication-title: Acta Neurologica Scandinavica – start-page: 2397 year: 2008 end-page: 2412 ident: bib0020 article-title: Childhood and juvenile absence epilepsies publication-title: Epilepsy: a comprehensive textbook – volume: 231 start-page: 225 year: 1984 end-page: 229 ident: bib0110 article-title: Therapeutic response of absence seizures in patients of an epilepsy clinic for adolescents and adults publication-title: Journal of Neurology – volume: 42 start-page: 282 year: 2001 end-page: 286 ident: bib0060 article-title: ILAE commission report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery publication-title: Epilepsia – volume: 46 start-page: 243 year: 2012 end-page: 245 ident: bib0025 article-title: Amantadine for the treatment of refractory absence seizures in children publication-title: Pediatric Neurology – volume: 52 start-page: 1510 year: 1999 end-page: 1512 ident: bib0075 article-title: Vagus nerve stimulation for medication-resistant generalized epilepsy, E04 VNS Study Group publication-title: Neurology – volume: 75 start-page: 432 year: 2010 end-page: 440 ident: bib0090 article-title: Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency publication-title: Neurology – volume: 6 start-page: 228 year: 2009 end-page: 237 ident: bib0065 article-title: Vagus nerve stimulation in the treatment of refractory epilepsy publication-title: Neurotherapeutics – volume: 194 start-page: 227 year: 1965 end-page: 232 ident: bib0105 article-title: Petit mal epilepsy, results of a prolonged follow-up study of 117 patients publication-title: JAMA – volume: 13 start-page: 959 year: 1963 end-page: 967 ident: bib0100 article-title: Prognosis of “Pure” petit mal; a follow-up study publication-title: Neurology – volume: 47 start-page: 802 year: 1996 end-page: 808 ident: bib0005 article-title: The outcome of absence epilepsy: a meta-analysis publication-title: Neurology – volume: 121 start-page: 819 year: 1992 end-page: 821 ident: bib0030 article-title: Effect of add-on amantadine therapy for refractory absence epilepsy publication-title: Journal of Pediatrics – volume: 1 start-page: 477 year: 2002 end-page: 482 ident: bib0070 article-title: Vagus-nerve stimulation for the treatment of epilepsy publication-title: Lancet Neurology – volume: 47 start-page: 115 year: 2006 end-page: 122 ident: bib0050 article-title: Refractory generalized seizures: response to corpus callosotomy and vagal nerve stimulation publication-title: Epilepsia – volume: 67 start-page: 489 year: 2010 end-page: 494 ident: bib0080 article-title: Operative and technical complications of vagus nerve stimulator implantation publication-title: Neurosurgery – volume: 18 start-page: 524 year: 2009 end-page: 529 ident: bib0085 article-title: Seizure frequency in children with epilepsy: factors influencing accuracy and parental awareness publication-title: Seizure – volume: 30 start-page: 389 year: 1989 end-page: 399 ident: bib0055 article-title: Proposal for revised classification of epilepsies and epileptic, syndromes. Commission on Classification and Terminology of the International League Against Epilepsy publication-title: Epilepsia – volume: 35 start-page: 579 year: 1985 end-page: 581 ident: bib0035 article-title: Amantadine in the treatment of refractory epilepsy in childhood: an open trial in 10 patients publication-title: Neurology – volume: 51 start-page: 1069 year: 2010 end-page: 1077 ident: bib0015 article-title: Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies publication-title: Epilepsia – volume: 7 start-page: 100 year: 1991 end-page: 104 ident: bib0095 article-title: Epidemiology of absence epilepsy: EEG findings and their predictive value publication-title: Pediatric Neurology – volume: 362 start-page: 790 year: 2010 ident: 10.1016/j.seizure.2013.01.008_bib0010 article-title: Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy publication-title: New England Journal of Medicine doi: 10.1056/NEJMoa0902014 – volume: 13 start-page: 340 year: 2004 ident: 10.1016/j.seizure.2013.01.008_bib0045 article-title: Effect of vagus nerve stimulation on adults with pharmacoresistant generalized epilepsy syndromes publication-title: Seizure doi: 10.1016/j.seizure.2003.09.002 – volume: 7 start-page: 100 year: 1991 ident: 10.1016/j.seizure.2013.01.008_bib0095 article-title: Epidemiology of absence epilepsy: EEG findings and their predictive value publication-title: Pediatric Neurology doi: 10.1016/0887-8994(91)90004-5 – volume: 231 start-page: 225 year: 1984 ident: 10.1016/j.seizure.2013.01.008_bib0110 article-title: Therapeutic response of absence seizures in patients of an epilepsy clinic for adolescents and adults publication-title: Journal of Neurology doi: 10.1007/BF00313944 – start-page: 2397 year: 2008 ident: 10.1016/j.seizure.2013.01.008_bib0020 article-title: Childhood and juvenile absence epilepsies – volume: 35 start-page: 579 year: 1985 ident: 10.1016/j.seizure.2013.01.008_bib0035 article-title: Amantadine in the treatment of refractory epilepsy in childhood: an open trial in 10 patients publication-title: Neurology doi: 10.1212/WNL.35.4.579 – volume: 13 start-page: 959 year: 1963 ident: 10.1016/j.seizure.2013.01.008_bib0100 article-title: Prognosis of “Pure” petit mal; a follow-up study publication-title: Neurology doi: 10.1212/WNL.13.11.959 – volume: 46 start-page: 243 year: 2012 ident: 10.1016/j.seizure.2013.01.008_bib0025 article-title: Amantadine for the treatment of refractory absence seizures in children publication-title: Pediatric Neurology doi: 10.1016/j.pediatrneurol.2012.02.004 – volume: 18 start-page: 524 year: 2009 ident: 10.1016/j.seizure.2013.01.008_bib0085 article-title: Seizure frequency in children with epilepsy: factors influencing accuracy and parental awareness publication-title: Seizure doi: 10.1016/j.seizure.2009.05.009 – volume: 75 start-page: 432 year: 2010 ident: 10.1016/j.seizure.2013.01.008_bib0090 article-title: Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency publication-title: Neurology doi: 10.1212/WNL.0b013e3181eb58b4 – volume: 30 start-page: 389 year: 1989 ident: 10.1016/j.seizure.2013.01.008_bib0055 article-title: Proposal for revised classification of epilepsies and epileptic, syndromes. Commission on Classification and Terminology of the International League Against Epilepsy publication-title: Epilepsia doi: 10.1111/j.1528-1157.1989.tb05316.x – volume: 51 start-page: 1069 year: 2010 ident: 10.1016/j.seizure.2013.01.008_bib0015 article-title: Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies publication-title: Epilepsia doi: 10.1111/j.1528-1167.2009.02397.x – volume: 52 start-page: 1510 year: 1999 ident: 10.1016/j.seizure.2013.01.008_bib0075 article-title: Vagus nerve stimulation for medication-resistant generalized epilepsy, E04 VNS Study Group publication-title: Neurology doi: 10.1212/WNL.52.7.1510 – volume: 1 start-page: 477 year: 2002 ident: 10.1016/j.seizure.2013.01.008_bib0070 article-title: Vagus-nerve stimulation for the treatment of epilepsy publication-title: Lancet Neurology doi: 10.1016/S1474-4422(02)00220-X – volume: 47 start-page: 802 year: 1996 ident: 10.1016/j.seizure.2013.01.008_bib0005 article-title: The outcome of absence epilepsy: a meta-analysis publication-title: Neurology doi: 10.1212/WNL.47.3.802 – volume: 6 start-page: 228 year: 2009 ident: 10.1016/j.seizure.2013.01.008_bib0065 article-title: Vagus nerve stimulation in the treatment of refractory epilepsy publication-title: Neurotherapeutics doi: 10.1016/j.nurt.2009.01.010 – volume: 187 start-page: 55 issue: Suppl. year: 2007 ident: 10.1016/j.seizure.2013.01.008_bib0040 article-title: Is vagus nerve stimulation a treatment option for patients with drug-resistant idiopathic generalized epilepsy? publication-title: Acta Neurologica Scandinavica doi: 10.1111/j.1600-0404.2007.00848.x – volume: 194 start-page: 227 year: 1965 ident: 10.1016/j.seizure.2013.01.008_bib0105 article-title: Petit mal epilepsy, results of a prolonged follow-up study of 117 patients publication-title: JAMA doi: 10.1001/jama.1965.03090160005001 – volume: 42 start-page: 282 year: 2001 ident: 10.1016/j.seizure.2013.01.008_bib0060 article-title: ILAE commission report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery publication-title: Epilepsia doi: 10.1046/j.1528-1157.2001.4220282.x – volume: 67 start-page: 489 year: 2010 ident: 10.1016/j.seizure.2013.01.008_bib0080 article-title: Operative and technical complications of vagus nerve stimulator implantation publication-title: Neurosurgery – volume: 121 start-page: 819 year: 1992 ident: 10.1016/j.seizure.2013.01.008_bib0030 article-title: Effect of add-on amantadine therapy for refractory absence epilepsy publication-title: Journal of Pediatrics doi: 10.1016/S0022-3476(05)81922-5 – volume: 47 start-page: 115 year: 2006 ident: 10.1016/j.seizure.2013.01.008_bib0050 article-title: Refractory generalized seizures: response to corpus callosotomy and vagal nerve stimulation publication-title: Epilepsia doi: 10.1111/j.1528-1167.2006.00377.x |
| SSID | ssj0009413 |
| Score | 2.2006838 |
| Snippet | A proportion of patients with childhood and juvenile absence epilepsies (CAE, JAE) are likely to be classified as medically refractory. In view of evidence gap... Abstract Purpose A proportion of patients with childhood and juvenile absence epilepsies (CAE, JAE) are likely to be classified as medically refractory. In... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 267 |
| SubjectTerms | Absence seizures Adolescent Anticonvulsants - therapeutic use Child Childhood absence epilepsy Epilepsy, Absence - drug therapy Epilepsy, Absence - physiopathology Epilepsy, Absence - therapy Female Follow-Up Studies Humans Juvenile absence epilepsy Male Medically refractory epilepsy Neurology Retrospective Studies Treatment Outcome Vagus nerve stimulation Vagus Nerve Stimulation - methods Young Adult |
| Title | Vagus nerve stimulation for medically refractory absence epilepsy |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1059131113000095 https://www.clinicalkey.es/playcontent/1-s2.0-S1059131113000095 https://dx.doi.org/10.1016/j.seizure.2013.01.008 https://www.ncbi.nlm.nih.gov/pubmed/23391567 https://www.proquest.com/docview/1326142300 |
| Volume | 22 |
| WOSCitedRecordID | wos000318057000003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1532-2688 dateEnd: 20210131 omitProxy: false ssIdentifier: ssj0009413 issn: 1059-1311 databaseCode: AIEXJ dateStart: 19950301 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9swFBZpO8Zexu7LLsWDvQV3sq1Y8mMY3bpByqDZyJuQJblkJE6w06zZ0376jiz5MprSbrAXEwyylHM-HR2dK0JvVTDUgRwarz9mPsnS0BdKD304-uB4lilghlXNJujpKZtOky-93q86F2Yzp3nOLi-T1X9lNbwDZpvU2b9gd_NReAG_genwBLbD81aM_ybOTdFVE8k4gP27cP25qnjChXXLzLcDOBiLqtXOdiDSstreegUSYlX-4ec907OfxsWwq_FH14hQbK0SKjZwxy8aUf-x0DOXUXMiTO77YHzUhgD9cK2QF6JjFxiL_FxU_cBt0w9dyuVgctS1TgSdWEBrMqvTZtoYJSNlQafzTZ2frhgOww7cSFem2n4d7ngObZ-RK5LfGiFMon5FFxO0F1UFWTFrj7omAPHMLMGswHjzjJq5hw5COkxALh6MPh1PP7eFm0lgkzTcktsssHc7J7tOv7nu_lLpMZMH6L67gHgjC5yHqKfzR-ju2IVYPEajCj9ehR-vgx8P8OM1-PFa_HgOP16Nnyfo64fjyfsT3_XZ8OWQ0bWfUUmwTGWYSmyMjLEIJU5kmigSYZHGiQwiQgiNqUpxpLI4EyoRTCUS3mgSR0_Rfr7M9XPkBSoLMiViKlRKMqwFUUxG8AGZYMki0Uekpg6Xrgi96YUy53W04XfuiMoNUTkOOBC1j46aYStbheWmAXFNel6nGMOhyAEtNw2kuwbq0u3wkge8DDnmVxDUR6wZ6bRXq5XeZtI3NTo4SHfjshO5Xl7AZHC7CuDGg3EfPbOwaQgQRqa5Q0xf_Ot_fYnutVv2FdpfFxf6NbojN-tZWRyiPTplh247_AYKe9cP |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vagus+nerve+stimulation+for+medically+refractory+absence+epilepsy&rft.jtitle=Seizure+%28London%2C+England%29&rft.au=Arya%2C+Ravindra&rft.au=Greiner%2C+Hansel+M.&rft.au=Lewis%2C+Amanda&rft.au=Mangano%2C+Francesco+T.&rft.date=2013-05-01&rft.pub=Elsevier+Ltd&rft.issn=1059-1311&rft.volume=22&rft.issue=4&rft.spage=267&rft.epage=270&rft_id=info:doi/10.1016%2Fj.seizure.2013.01.008&rft.externalDocID=S1059131113000095 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10591311%2FS1059131113X00044%2Fcov150h.gif |